13 research outputs found
Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application
Get PDFAbstractFrom 2006 to 2011, Roslin Cells Ltd derived 17 human embryonic stem cells (hESC) while developing (RCM1, RC-2 to -8, -10) and implementing (RC-9, -11 to -17) quality assured standards of operation in a facility operating in compliance with European Union (EU) directives and United Kingdom (UK) licensure for procurement, processing and storage of human cells as source material for clinical application, and targeted to comply with an EU Good Manufacturing Practice specification. Here we describe the evolution and specification of the facility, its operation and outputs, complementing hESC resource details communicated in Stem Cell Research Lab Resources
Conscious Sedation During Electrophysiology Testing and Radiofrequency Catheter Ablation
No full textOligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system.
No full textSpecificity of systolic anterior motion of anterior mitral leaflet for hypertrophic cardiomyopathy. Prevalence in large population of patients with other cardiac diseases.
No full textTHE WERNICKE SYNDROME: With Special Reference to Manic Syndromes Associated with Hypothalamic Lesions
No full text
